Chenaf C, Delorme J, Delage N, Ardid D, Eschalier A, Authier N. Prevalence of chronic pain with or without neuropathic characteristics in France using the capture-recapture method: a population-based study. Pain 2018; 159: 2394-402.
Kuehn B. Chronic pain prevalence. JAMA 2018; DOI: https://doi.org/10.1001/jama.2018.16009.
Macfarlane GJ. The epidemiology of chronic pain. Pain 2016; 157: 2158-9.
Steingrímsdóttir ÓA, Landmark T, Macfarlane GJ, Nielsen CS. Defining chronic pain in epidemiological studies: a systematic review and meta-analysis. Pain 2017; 158: 2092-107.
Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res 2016; 9: 457-67.
Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D,. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006; DOI: https://doi.org/10.1016/j.ejpain.2005.06.009.
Franklin GM; American Academy of Neurology. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014; 83: 1277-84.
Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I--evidence assessment. Pain Physician 2012; 15(3 Suppl): S1-65.
Nadeau SE. Opioids for chronic noncancer pain: to prescribe or not to prescribe-what is the question? Neurology 2015; 85: 646-51.
Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 2014; 17: E119-28.
Dart RC, Surratt HL, Cicero TJ, et al, Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015; 372: 241-8.
Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-35.
Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016; 387: 1644-56.
Chenaf C, Kaboré JL, Delorme J, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain 2019; 23: 124-34.
Shipton EA, Shipton EE, Shipton AJ . A review of the opioid epidemic: what do we do about it? Pain Ther 2018; 7: 23-36.
Helmerhorst GT, Teunis T, Janssen SJ, Ring D. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Bone Joint J 2017; 99-B: 856-64.
Jani M, Dixon WG. Opioids are not just an American problem. BMJ 2017; DOI: https://doi.org/10.1136/bmj.j5514.
European Monitoring Center for Drugs and Drug Addiction. European Drug Report 2018: Trends and Developments. Available from URL: https://www.emcdda.europa.eu/publications/edr/trends-developments/2018_en (accessed December 2021).
National Institute on Drug. Overdose Death Rates. In: National Institute on Drug Abuse. Available from URL: https://www.drugabuse.gov/drug-topics/trends-statistics/overdose-death-rates (accessed December 2021)
National Institute on Drug Abuse Abuse. Fentanyl and Other Synthetic Opioids Drug Overdose Deaths. Available from URL: https://www.drugabuse.gov/drug-topics/trends-statistics/infographics/fentanyl-other-synthetic-opioids-drug-overdose-deaths (accessed December 2021).
Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med 2015; 80: 5-9.
Chenaf C, Kabore JL, Delorme J, et al. Codeine shopping behavior in a retrospective cohort of chronic noncancer pain patients: incidence and risk factors. J Pain 2016; 17: 1291-301.
Chenaf C, Kabore JL, Delorme J, et al. Incidence of tramadol shopping behavior in a retrospective cohort of chronic non-cancer pain patients in France. Pharmacoepidemiol Drug Saf 2016; 25: 1088-98.
Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician 2017; 20: S111-33.
Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain 2007; 130: 144-56.
Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat 2008; 35: 380-6.
Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.
Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186-91.
Repo JP, Rosqvist E. Guidelines for translation and cross-cultural adaptation of non-technical skills rating instruments. Value Health 2016; DOI: https://doi.org/10.1016/j.jval.2016.09.072.
Vetter TR, Cubbin C. Psychometrics: trust, but verify. Anesth Analg 2019; 128: 176-81.
Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-49.
Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012; 21: 651-7.
Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.
Agence nationale de sécurité du médicament et des produits de santé. Antalgiques opioïdes: l’ANSM publie un état des lieux de la consommation en France - ANSM. Available from URL: https://ansm.sante.fr/actualites/antalgiques-opioides-lansm-publie-un-etat-des-lieux-de-la-consommation-en-france.
Kibaly C, Alderete JA, Liu SH, et al. Oxycodone in the opioid epidemic: high ‘liking’, ‘wanting’, and abuse liability. Cell Mol Neurobiol 2020; DOI: https://doi.org/10.1007/s10571-020-01013-y.
Moisset X, Martinez V. Opioid use for the management of chronic non-cancer pain: French guidelines. Rev Neurol (Paris) 2016; 172: 337-8.
Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007; 11: 490-518.
Latkin CA, Edwards C, Davey-Rothwell MA, Tobin KE. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict Behav 2017; 73: 133-6.
Tompkins DA, Huhn AS, Johnson PS, et al. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction 2018; 113: 67-79.
McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain 2016; 17: 806-14.